Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biomarin Pharmaceuticals
(NQ:
BMRN
)
83.51
-0.73 (-0.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,476,412
Open
83.57
Bid (Size)
77.00 (13)
Ask (Size)
85.25 (5)
Prev. Close
84.24
Today's Range
83.07 - 84.75
52wk Range
73.67 - 99.56
Shares Outstanding
183,352,255
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
For those who appreciate growth without the sticker shock, NASDAQ:BMRN is worth considering.
June 11, 2024
While growth is established for BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN), the stock's valuation remains reasonable.
Via
Chartmill
CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump
June 07, 2024
KKR and GoDaddy also will join before the open on June 24.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Performance
YTD
-14.83%
-14.83%
1 Month
+3.87%
+3.87%
3 Month
-0.43%
-0.43%
6 Month
-14.05%
-14.05%
1 Year
-12.87%
-12.87%
More News
Read More
June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge
June 05, 2024
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
June 04, 2024
Via
Benzinga
Looking Into Biomarin Pharmaceutical's Recent Short Interest
May 28, 2024
Via
Benzinga
NASDAQ:BMRN is not too expensive for the growth it is showing.
May 21, 2024
Via
Chartmill
Analyst Ratings For Biomarin Pharmaceutical
May 14, 2024
Via
Benzinga
BridgeBio Stock Makes A Bullish Move On Dwarfism Treatment Results
June 04, 2024
Via
Investor's Business Daily
Li Auto Was One Of The Worst-Performing Stocks Last Week: Are These 10 Large-Cap Stocks Losers In Your Portfolio? (May 12-May 18, 2024)
May 19, 2024
Via
Benzinga
4 Incomparable Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
May 18, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Walmart To Rally Over 17%? Here Are 10 Top Analyst Forecasts For Friday
May 17, 2024
Via
Benzinga
(BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest
May 09, 2024
Via
Benzinga
Deep Dive Into Biomarin Pharmaceutical Stock: Analyst Perspectives (8 Ratings)
April 25, 2024
Via
Benzinga
Looking Into Biomarin Pharmaceutical's Recent Short Interest
April 03, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 15, 2024
Via
Benzinga
The 3 Best Biotech Stocks to Buy in May 2024
May 09, 2024
Via
InvestorPlace
Citi Just Cut Its Price Target on These 3 Stocks
May 03, 2024
Via
InvestorPlace
For those who appreciate growth without the sticker shock, NASDAQ:BMRN is worth considering.
April 30, 2024
Via
Chartmill
4 Dominant Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
April 27, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 25, 2024
Via
Benzinga
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
April 25, 2024
Via
InvestorPlace
BMRN Stock Earnings: Biomarin Pharmaceutical Beats EPS, Misses Revenue for Q1 2024
April 24, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 24, 2024
Via
Benzinga
Don't overlook NASDAQ:BMRN—a stock with solid growth prospects and a reasonable valuation.
April 08, 2024
Via
Chartmill
While growth is established for NASDAQ:BMRN, the stock's valuation remains reasonable.
March 18, 2024
Via
Chartmill
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.